arrow
K

Kanta Subbarao

peter doherty institute
H指数:100
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults

COVID-19预免疫和加强平台试验(PICOBOO):在免疫健全成人中作为第五剂或后续加强剂接种的七种获批COVID-19疫苗的免疫原性、反应原性和安全性

Vaccine
IF3.5
2026-07-010
PRE
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses

季节性流感病毒遗传变异追踪的命名法

2026-02-130
OAAI
Antibody responses following COVID-19 vaccination and breakthrough infections in naïve and convalescent individuals suggest imprinting to the ancestral strain of SARS-CoV-2

COVID-19疫苗接种和突破性感染后,在初次感染者和康复者中观察到的抗体反应表明,这些反应对SARS-CoV-2的祖先毒株存在印迹现象。

MBIO
IF4.7
2025-12-010
PRE
Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18-55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial

一项利用第二代分子夹稳定前融合构象的严重急性呼吸综合征冠状病毒2刺突亚单位疫苗的安全性与免疫原性研究:一项在18-55岁成人中进行的随机、双盲、活性对照、I期临床试验

2025-12-010
PRE
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination

实体瘤恶性患者中失调的炎症塑造了针对COVID-19疫苗接种的多功能抗体反应

2025-10-060
OA
Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination

卡介苗接种对SARS-CoV-2及COVID-19疫苗接种的免疫反应的影响

2025-01-250
OAAI
Antibody responses against influenza A decline with successive years of annual influenza vaccination
2025-01-171
OAAI
The Platform Trial I n CO VID-19 Priming and BOO sting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old

VID-19启动和BOO sting (PICOBOO) 的平台试验: 在AZD1222启动的50-<70岁的个体中作为第二次加强剂 (第四剂) 施用的不同新型冠状病毒肺炎疫苗的免疫原性,反应原性和安全性

2024-12-011
OAAI
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
2024-09-254
OA
Speci fi c and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines - an exploratory sub-study of the BRACE trial

新型冠状病毒肺炎接种ChAdOx1-S和BNT162b2疫苗后的特异性和脱靶免疫反应-BRACE试验的探索性子研究

2024-05-011
OAAI